NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 341 filers reported holding NEKTAR THERAPEUTICS in Q2 2019. The put-call ratio across all filers is 2.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,396,000 | -1.0% | 713,769 | -6.5% | 3.53% | +5.8% |
| Q1 2019 | $25,650,000 | +6.9% | 763,403 | +4.5% | 3.33% | -12.9% |
| Q4 2018 | $24,003,000 | +5.7% | 730,226 | +96.0% | 3.83% | +4.4% |
| Q3 2018 | $22,711,000 | +24.3% | 372,551 | -0.5% | 3.66% | +28.8% |
| Q2 2018 | $18,275,000 | -42.7% | 374,251 | +24.7% | 2.84% | -59.4% |
| Q1 2018 | $31,887,000 | +51.8% | 300,086 | -14.7% | 7.00% | +21.6% |
| Q4 2017 | $21,006,000 | +73.9% | 351,741 | -30.1% | 5.76% | +50.6% |
| Q3 2017 | $12,077,000 | +31.4% | 503,193 | +7.0% | 3.82% | +24.0% |
| Q2 2017 | $9,192,000 | +75.3% | 470,194 | +110.5% | 3.08% | +54.0% |
| Q1 2017 | $5,244,000 | – | 223,421 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |